NIH Funds Allen to Explore Insulin-Linked Metabolic Pathway
Continuing their highly productive (32 publications), 20-year collaboration, Professor Karen Allen and Dr. Debra Dunaway-Mariano, University of New Mexico, have received a 4-year, $1.26 million award from the NIH. The team is known for much of the current understanding of catalysis and specificity of the Haloalkanoic Acid Dehalogenase Superfamily (HADSF). This current award, “Structure and […]
NIH Funds Porco Group to Synthesize Bioactive Natural Products
The Porco Research Group has received a 4-year, $1.2 million award from the National Institutes of Health for their proposal, Chemical Synthesis of Bioactive Flavonoid and Xanthone-Derived Natural Products. Undertaken in conjunction with biological collaborators, including Professor Tom Gilmore (BU Biology) and Dr. John Beutler of the National Cancer Institute’s Center for Cancer Research, the […]
John Straub Serves as Phi Beta Kappa Visiting Scholar
The Phi Beta Kappa’s Visiting Scholar Program (VSP) offers undergraduates the opportunity to spend time with some of America’s most distinguished scholars. It aims to contribute to the intellectual life of the campus by making possible an exchange of ideas between the Visiting Scholars and the resident faculty and students. Professor John Straub is one of the 14 […]
Elliott Group Research Featured in Biochemistry
The Biochemistry Journal reports on research conducted by Professor Sean Elliott and his Research Group and their collaborators at MIT; Professor Catherine Drennan and her Research Group. Their research provides strong evidence that Flavin Adenine Dinucleotide (FAD) plays a structural role in the formation of tetrameric AidB. While their studies clearly show FAD-dependent oligomerization of […]
NIH Funds Alkaloid Synthesis Research
The Stephenson Group Receives NIH Funding for Alkaloid Synthesis using Visible Light. These visible light-mediated methods provide innovative avenues toward challenging molecular architectures with broad biological activity.
Finding NEMO: Multidisciplinary Team Searches for the Drugs of the Future
There are many medically important drug targets that current drug discovery technology is not able to address. Collaborative basic research in Chemistry, Biology, and Biochemistry is key to solving these intractable problems to enable the discovery of new classes of drugs. A multidisciplinary team at Boston University, led by Associate Professor of Chemistry Adrian Whitty, […]